Cite
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
MLA
Deng Y, et al. “Prognostic Significance of Pretreatment Albumin/Globulin Ratio in Patients with Hepatocellular Carcinoma.” OncoTargets and Therapy, vol. ume 9, Aug. 2016, pp. 5317–28. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.b449ebc7ebd4c138d2d46348ca02a11&authtype=sso&custid=ns315887.
APA
Deng Y, Pang Q, Miao RC, Chen W, Zhou YY, Bi JB, Liu SS, Zhang JY, Qu K, & Liu C. (2016). Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma. OncoTargets and Therapy, ume 9, 5317–5328.
Chicago
Deng Y, Pang Q, Miao RC, Chen W, Zhou YY, Bi JB, Liu SS, Zhang JY, Qu K, and Liu C. 2016. “Prognostic Significance of Pretreatment Albumin/Globulin Ratio in Patients with Hepatocellular Carcinoma.” OncoTargets and Therapy ume 9 (August): 5317–28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.b449ebc7ebd4c138d2d46348ca02a11&authtype=sso&custid=ns315887.